The effects of KN-93 were independent of the liver kinase B1–adenosine monophosphate-activated protein kinase (AMPK) pathway, and the combination of KN-93 and metformin, an AMPK activator, had additive inhibitory effects on mTOR signaling and in vitro cyst growth. Here, MTOR is linked to cyst.